TELO:NASDAQTelomir Pharmaceuticals, Inc. Analysis
Data as of 2026-09-01 - not real-time
$1.11
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Telomir Pharmaceuticals, Inc. trades at $1.11, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has gained 2.9%. Relative strength is 45.3 — neutral — and the MACD signal is bullish. Watch $1.03 as support and $1.21 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 61.3%, a beta of 1.83 and a maximum drawdown of 52.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 61.3%, a beta of 1.83 and a maximum drawdown of 52.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.
Top Market Events
Biomednewsbreaks - Telomir Pharmaceuticals NASDAQ: TELO Reports Peer-Reviewed Telomir-Zn Data Supporting Phase 1/2 TNBC...Yahoo Finance22dTelomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.28
- MACD momentum is positive
Medium Term
1–3 yearsCautious
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.28
- 30-day volatility of 61.3%
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Negative return on equity of -213.1%
- Negative free cash flow
- 30-day volatility of 61.3%
Key Metrics & Analysis
Financial Health
P/E Ratio-4.0
ROE-213.10%
ROA-122.81%
Debt/Equity2.72
P/B Ratio7.7
Op. Cash Flow$-4914453
Free Cash Flow$-3069583
Industry P/E30.7
Technical Analysis
TrendBearish
RSI45.3
Support$1.03
Resistance$1.21
MA 20$1.14
MA 50$1.18
MA 200$1.28
MACDBullish
VolumeIncreasing
Fear & Greed Index93.38
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.83
Volatility61.34%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.